Neuronetics (STIM) Financials: History & Chart

Neuronetics, Inc.(STIM)

Medical - Devices · Malvern, PA

$2.22+0.01 (+0.68%)

Delayed quote: Oct 6, 2026, 2:40 PM EDT

About Neuronetics, Inc.

Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.

Malvern, PA

658 employees

www.neurostar.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Daniel L. Reuvers

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	155.10M	41.57M	34.45M	41.78M	37.30M	38.11M	31.98M	22.49M	18.53M
Cost of Goods Sold	78.91M	20.34M	18.30M	20.07M	20.19M	20.35M	16.24M	7.60M	4.53M
Gross Profit	76.19M	21.22M	16.15M	21.70M	17.11M	17.76M	15.74M	14.89M	14.00M
Gross Profit Margin	49.1%	51.1%	46.9%	52.0%	45.9%	46.6%	49.2%	66.2%	75.6%
Total Operating Expenses	99.05M	22.72M	25.15M	26.75M	24.43M	25.82M	26.75M	26.36M	21.73M
Research & Development	5.87M	1.34M	1.36M	1.67M	1.50M	1.80M	1.62M	5.77M	2.42M
Selling, General & Administrative	93.18M	21.39M	23.79M	25.08M	22.93M	24.02M	25.14M	20.59M	19.31M
Operating Income (EBIT)	-22.86M	-1.50M	-8.99M	-5.04M	-7.32M	-8.06M	-11.01M	-11.47M	-7.73M
Operating Margin	-14.7%	-3.6%	-26.1%	-12.1%	-19.6%	-21.1%	-34.4%	-51.0%	-41.7%
Income Before Tax (EBT)	-30.82M	-3.44M	-10.79M	-7.19M	-9.40M	-9.87M	-12.69M	-12.72M	-13.34M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	8.57M	2.13M	2.27M	2.10M	2.08M	1.97M	1.92M	1.60M	1.73M
Other Income/Expense	-7.96M	-1.94M	-1.79M	-2.15M	-2.08M	-1.81M	-1.68M	-1.25M	-5.61M
Net Income	-30.43M	-3.44M	-10.79M	-7.16M	-9.04M	-10.12M	-12.68M	-12.66M	-13.34M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-19.6%	-8.3%	-31.3%	-17.1%	-24.3%	-26.6%	-39.6%	-56.3%	-72.0%
EBITDA	-19.73M	-772K	-8.25M	-4.28M	-6.43M	-7.16M	-10.10M	-11.03M	-7.22M
EBITDA Margin	-12.7%	-1.9%	-23.9%	-10.2%	-17.3%	-18.8%	-31.6%	-49.0%	-38.9%
Depreciation & Amortization	3.13M	729K	745K	767K	886K	901K	911K	446K	512K
EPS Basic	-0.43	-0.04	-0.16	-0.10	-0.13	-0.15	-0.21	-0.33	-0.44
EPS Diluted	-0.43	-0.04	-0.16	-0.10	-0.13	-0.15	-0.21	-0.33	-0.44
Weighted Average Basic Shares	71.37M	71.37M	69.59M	68.76M	67.31M	66.18M	61.47M	36.67M	30.27M
Weighted Average Diluted Shares	71.37M	71.37M	69.59M	68.76M	67.31M	66.18M	61.47M	36.67M	30.27M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	149.16M	74.89M	71.35M	65.21M	55.31M	49.24M	62.66M	52.78M
Cost of Goods Sold	76.85M	20.73M	19.64M	15.48M	11.65M	11.55M	15.39M	12.45M
Gross Profit	72.31M	54.16M	51.70M	49.72M	43.66M	37.69M	47.27M	40.33M
Gross Profit Margin	48.5%	72.3%	72.5%	76.3%	78.9%	76.5%	75.4%	76.4%
Total Operating Expenses	103.74M	88.72M	82.26M	84.83M	71.22M	60.00M	74.20M	60.16M
Research & Development	6.58M	12.77M	9.52M	9.34M	7.92M	9.20M	13.75M	8.23M
Selling, General & Administrative	97.16M	75.95M	72.74M	75.50M	63.30M	50.80M	60.45M	51.93M
Operating Income (EBIT)	-31.44M	-34.56M	-30.55M	-35.11M	-27.56M	-22.31M	-26.93M	-19.83M
Operating Margin	-21.1%	-46.2%	-42.8%	-53.8%	-49.8%	-45.3%	-43.0%	-37.6%
Income Before Tax (EBT)	-39.00M	-43.74M	-30.19M	-37.21M	-31.17M	-27.45M	-29.04M	-24.10M
Interest Income	N/A	N/A	24K	N/A	N/A	N/A	N/A	N/A
Interest Expense	8.41M	7.29M	5.42M	3.60M	3.30M	4.52M	3.69M	3.69M
Other Income/Expense	-7.56M	-9.18M	365K	-2.10M	-3.61M	-5.14M	-2.11M	-4.26M
Net Income	-39.00M	-43.71M	-30.19M	-37.16M	-31.19M	-27.45M	-29.04M	-24.10M
Income Tax Expense	0.00	-14K	-24K	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-26.1%	-58.4%	-42.3%	-57.0%	-56.4%	-55.7%	-46.4%	-45.7%
EBITDA	-27.97M	-32.49M	-28.55M	-33.46M	-26.50M	-21.37M	-25.86M	-18.95M
EBITDA Margin	-18.8%	-43.4%	-40.0%	-51.3%	-47.9%	-43.4%	-41.3%	-35.9%
Depreciation & Amortization	3.46M	2.07M	2.01M	1.65M	1.06M	941K	1.06M	882K
EPS Basic	-0.59	-1.38	-1.05	-1.38	-1.22	-1.46	-1.87	-2.69
EPS Diluted	-0.59	-1.38	-1.05	-1.38	-1.22	-1.46	-1.87	-2.69
Weighted Average Basic Shares	65.95M	31.73M	28.66M	26.90M	25.48M	18.84M	18.38M	8.95M
Weighted Average Diluted Shares	65.95M	31.73M	28.66M	26.90M	25.48M	18.84M	18.38M	8.95M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.